| (USD) | Jun 2026 | Y/Y change |
|---|---|---|
| Revenue | 0.00 | — |
| Operating expense | — | — |
| Net income | -1.27M | — |
| Net profit margin | — | — |
| Earnings per share | — | — |
| EBITDA | — | — |
| Effective tax rate | — | — |
Over the past year, INMB returned -1.2% with dividends reinvested.
| Period | Total return |
|---|---|
| YTD | +52.6% |
| 1 year | -1.2% |
| 5 years | -90.0% |
| All-time high | $23.72 (Aug 2021) |
Returns are total returns and include reinvested dividends. The all-time high is the highest monthly closing price on record.
See what $1,000 in INMB would be worth today ›No. INmune Bio Inc. has not paid a dividend in the past 12 months.
INmune Bio Inc. stock trades on NASDAQ under the ticker symbol INMB.
INmune Bio Inc. is part of the Healthcare sector.
INmune Bio Inc. has a market cap of 66.05M USD, based on the latest quote.
INmune Bio Inc. is expected to report earnings around Oct 29, 2026. That date is an estimate and has not been confirmed by the company.
